OGIVRI

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 83257-003
  • Application number BLA761074
  • SPL ID ed1bbb0a-ad1a-6cb6-e955-e9ae2ce9c40f
  • SPL set ID b6465b44-a6dd-f99c-d009-6851cf05169c
  • UNII P188ANX8CK
  • RxCUI 2179753
  • RxCUI 2179758
  • RxCUI 2179760
  • RxCUI 2179763

What the source publishes

Labeler
Biocon Biologics Inc.
Active ingredients
trastuzumab-dkst
Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:83257-003_ed1bbb0a-ad1a-6cb6-e955-e9ae2ce9c40f
{
  "name": "OGIVRI",
  "splId": "ed1bbb0a-ad1a-6cb6-e955-e9ae2ce9c40f",
  "labels": [
    {
      "setId": "b6465b44-a6dd-f99c-d009-6851cf05169c",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6465b44-a6dd-f99c-d009-6851cf05169c",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=b6465b44-a6dd-f99c-d009-6851cf05169c"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Biocon Biologics Inc.",
  "finished": true,
  "packaging": [],
  "productId": "83257-003_ed1bbb0a-ad1a-6cb6-e955-e9ae2ce9c40f",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
  "productNdc": "83257-003",
  "deaSchedule": null,
  "genericName": "trastuzumab-dkst",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TRASTUZUMAB",
      "strength": "420 mg/20mL"
    }
  ],
  "applicationNumber": "BLA761074",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20231001",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175661",
      "N0000020008"
    ],
    "unii": [
      "P188ANX8CK"
    ],
    "rxcui": [
      "2179753",
      "2179758",
      "2179760",
      "2179763"
    ],
    "spl_set_id": [
      "b6465b44-a6dd-f99c-d009-6851cf05169c"
    ],
    "pharm_class_epc": [
      "HER2/neu Receptor Antagonist [EPC]"
    ],
    "pharm_class_moa": [
      "HER2/Neu/cerbB2 Antagonists [MoA]"
    ],
    "manufacturer_name": [
      "Biocon Biologics Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:83257-003_ed1bbb0a-ad1a-6cb6-e955-e9ae2ce9c40f"